RecruitingNot ApplicableNCT04694248

Anticoagulant Plus Antiplatelet Therapy Following Iliac Vein Stenting

Sponsor

First Affiliated Hospital of Zhejiang University

Enrollment

172 participants

Start Date

Nov 3, 2021

Study Type

INTERVENTIONAL

Conditions

Deep Vein Thrombosis Iliac Vein Thrombosis Iliac Vein Obstruction Iliac Vein Stenosis Iliac Vein Compression Syndrome

Summary

To evaluate the efficacy and safety of combination of anticoagulant and antiplatelet therapy on the patency of iliac vein at 12-month post stenting in patients with acute proximal DVT and ipsilateral iliac vein stenosis who received percutaneous mechanic thrombectomy and iliac vein stenting.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Aspirin and a drug called Rivaroxaban for people with deep vein thrombosis, iliac vein compression syndrome, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.